---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-090546"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:48:38.774435+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sagimet Biosciences enters into $75M ATM equity sales agreement with Cantor Fitzgerald

## Summary
- Controlled Equity Offering Sales Agreement with Cantor Fitzgerald dated August 15, 2024.
- Company may sell up to $75M of Series A common stock through at-the-market offerings.
- Agent entitled to commission of up to 3% of gross proceeds from each sale.
- Company has no obligation to sell shares and may suspend or terminate at any time.
- Registration statement on Form S-3 filed same day; sales only after SEC declares effective.

## SEC filing metadata
- accession: 0001104659-24-090546
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/0001104659-24-090546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/tm2421627d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-090546
- JSON: https://secwatch.observer/filing/0001104659-24-090546.json
- Plain text: https://secwatch.observer/filing/0001104659-24-090546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.